tradingkey.logo
tradingkey.logo
Search

AC Immune SA

ACIU
Add to Watchlist
2.210USD
-0.030-1.34%
Close 07-23 16:00ETQuotes delayed by 15 min
224.92MMarket Cap
LossP/E TTM

ACIU Financials

See AC Immune SA's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

AC Immune SA Earnings Date

Latest Release
Mar 13, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
4.52M
-85.42%
EPS(YoY)
-0.88
-56.76%
Analyst Rating
STRONG BUY
2026/07/24
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
12.43%-0.19
-3.07%-0.18
-402.85%-0.20
-4.37%-0.27
-7.54%-0.21
-167.96%-0.17
133.37%0.07
-14.49%-0.25
12.93%-0.20
73.21%-0.06
---0.20
---0.22
---0.23
---0.24
---0.62
----
----
----
----
----
----
Revenue
19.51%1.43M
-66.86%427.20K
-96.08%1.16M
100.36%1.62M
--1.20M
-92.30%1.29M
--29.53M
--807.00K
--0.00
1555863.92%16.75M
-100.00%0.00
--0.00
--0.00
--1.08K
--3.95M
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
Net Profit
17.76%-18.95M
-1.42%-18.17M
-406.91%-19.57M
1.88%-26.23M
-17.14%-23.04M
-233.71%-17.91M
138.53%6.38M
-38.61%-26.74M
-0.42%-19.67M
73.40%-5.37M
-21.98%-16.55M
6.24%-19.29M
-1.02%-19.59M
11.47%-20.18M
22.13%-13.57M
2.17%-20.57M
-5.37%-19.39M
-9.16%-22.79M
16.28%-17.43M
-21.37%-21.03M
----
Net Margin
31.19%-1322.70%
-206.07%-4252.37%
-7921.10%-1688.82%
51.03%-1622.43%
---1922.12%
-4234.71%-1389.36%
--21.59%
---3312.95%
----
100.00%-32.05%
----
----
----
---1874900.00%
---1321.91%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
--100.00%
--100.00%
----
0.00%100.00%
----
----
----
--100.00%
--100.00%
----
----
----
----
----
----
Debt to assets ratio
27.75%3.13%
25.26%2.94%
115.18%2.72%
90.23%2.59%
23.19%2.45%
22.86%2.35%
-24.58%1.26%
-16.02%1.36%
26.26%1.99%
26.98%1.91%
--1.67%
--1.62%
--1.58%
--1.51%
--1.21%
----
----
----
----
----
----
Revenue
19.51%1.43M
-66.86%427.20K
-96.08%1.16M
100.36%1.62M
--1.20M
-92.30%1.29M
--29.53M
--807.00K
--0.00
1555863.92%16.75M
-100.00%0.00
--0.00
--0.00
--1.08K
--3.95M
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
----
Operating profit
19.28%-18.93M
13.75%-18.21M
-330.02%-19.38M
2.51%-24.00M
-6.13%-23.45M
-426.92%-21.11M
149.83%8.42M
-26.06%-24.62M
-12.45%-22.10M
80.09%-4.01M
-25.07%-16.90M
6.09%-19.53M
-1.45%-19.65M
17.60%-20.12M
39.13%-13.52M
-0.92%-20.80M
-2.11%-19.37M
-17.15%-24.42M
-7.75%-22.20M
-19.33%-20.61M
----
Net Profit
17.76%-18.95M
-1.42%-18.17M
-406.91%-19.57M
1.88%-26.23M
-17.14%-23.04M
-233.71%-17.91M
138.53%6.38M
-38.61%-26.74M
-0.42%-19.67M
73.40%-5.37M
-21.98%-16.55M
6.24%-19.29M
-1.02%-19.59M
11.47%-20.18M
22.13%-13.57M
2.17%-20.57M
-5.37%-19.39M
-9.16%-22.79M
16.28%-17.43M
-21.37%-21.03M
----
Current assets
-44.36%102.49M
-37.32%122.25M
-35.42%140.39M
-23.05%163.19M
52.24%184.20M
37.72%195.03M
130.79%217.39M
86.66%212.08M
-3.14%120.99M
2.71%141.61M
-36.43%94.19M
-31.51%113.62M
-31.42%124.92M
-36.51%137.87M
-30.72%148.18M
-25.83%165.88M
-24.88%182.14M
-12.50%217.16M
-22.11%213.88M
-23.96%223.65M
----
Total current liabilities
-1.72%118.10M
4.67%119.68M
3.66%121.31M
3.76%122.53M
672.61%120.17M
644.37%114.34M
814.37%117.03M
824.03%118.09M
29.30%15.55M
24.31%15.36M
-6.26%12.80M
2.33%12.78M
-1.83%12.03M
-42.42%12.36M
-12.31%13.65M
-4.41%12.49M
0.16%12.25M
42.97%21.46M
2.61%15.57M
-8.34%13.06M
----
Total assets
-31.16%175.93M
-25.54%194.96M
-25.17%211.81M
-15.59%235.51M
38.74%255.58M
26.58%261.84M
81.11%283.05M
55.87%279.03M
-2.63%184.21M
3.36%206.85M
-24.27%156.29M
-21.15%179.02M
-21.91%189.18M
-28.57%200.13M
-7.32%206.36M
-2.46%227.05M
-3.35%242.28M
9.59%280.19M
-20.82%222.66M
-22.62%232.79M
----
Total liabilities
-3.72%135.56M
2.75%138.23M
1.91%134.74M
6.66%142.98M
465.74%140.80M
436.28%134.53M
598.29%132.21M
592.18%134.04M
37.23%24.89M
37.53%25.09M
21.65%18.93M
32.32%19.37M
-17.57%18.14M
-42.23%18.24M
-41.19%15.56M
-39.14%14.64M
-2.60%22.00M
26.76%31.58M
3.36%26.46M
-2.46%24.05M
----
Total equity
-64.83%40.37M
-55.44%56.73M
-48.91%77.07M
-36.17%92.54M
-27.96%114.78M
-29.96%127.30M
9.82%150.85M
-9.19%144.98M
-6.86%159.32M
-0.07%181.76M
-28.01%137.35M
-24.84%159.65M
-22.35%171.05M
-26.84%181.89M
-2.75%190.80M
1.76%212.41M
-3.42%220.28M
7.74%248.61M
-23.24%196.19M
-24.42%208.74M
----
Net operating income
----
-410.08%-20.86M
-38.11%-22.64M
-122.51%-19.31M
-2120.38%-22.78M
136.73%6.73M
-12.75%-16.39M
630.34%85.78M
106.00%1.13M
2.22%-18.32M
-6.97%-14.54M
20.72%-16.18M
21.07%-18.79M
1.94%-18.74M
14.38%-13.59M
-15.47%-20.40M
-24.86%-23.81M
7.86%-19.11M
7.13%-15.87M
-7.93%-17.67M
-89.92%-19.07M
Net investment
----
566.22%20.23M
1152.70%25.46M
133.20%29.57M
114.13%3.67M
-116.47%-4.34M
-146.88%-2.42M
-1407.70%-89.06M
-154.20%-25.95M
393.51%26.34M
200.35%5.16M
-123.05%-5.91M
8717.37%47.87M
122.93%5.34M
-848.76%-5.14M
175.79%25.62M
36.05%-555.50K
-621.80%-23.28M
-103.35%-541.87K
-419.04%-33.81M
-295.38%-868.70K
Net financing
----
-47.68%-329.88K
-56.37%-313.50K
-319.89%-305.81K
58.77%-312.39K
-100.48%-223.38K
-140.94%-200.49K
-103.32%-72.83K
-380.42%-757.63K
28663.53%46.42M
443.49%489.67K
1629.31%2.19M
83.26%-157.70K
-100.53%-162.52K
-103.01%-142.56K
-584.80%-143.49K
-111.12%-942.29K
6350.99%30.79M
3030.97%4.73M
82.21%-20.95K
2286.46%8.47M

FAQs

What is the total revenue of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its total revenue reached 4.52M, with a year-on-year change of 30.97M.

What are the current assets of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its current assets were 122.25M, with a year-on-year change of -37.32.

What are the total assets of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its total assets of AC Immune SA were 194.96M, with a year-on-year change of -25.54.

What are the total liabilities of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its total liabilities of AC Immune SA were 138.23M, with a year-on-year change of 2.75.

What is the total equity of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its total equity of AC Immune SA was 56.73M, with a year-on-year change of -55.44.

What is the net operating income of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its net operating income of AC Immune SA was -87.04M, with a year-on-year change of -46.54.

What is the net investment of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its net investment of AC Immune SA was 80.31M, with a year-on-year change of 167.27.

What is the net financing of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its net financing of AC Immune SA was -1.29M, with a year-on-year change of -1.51.

What is the Earnings Per Share (EPS) of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its Earnings Per Share (EPS) was -0.88, with a year-on-year change of -56.76.

What is the net income of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its net income was -89.04M, with a year-on-year change of -54.22.

What is the net margin of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its net profit margin was -1971.65, with a year-on-year change of -957.50.

What is the debt-to-asset ratio of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its debt-to-asset ratio was 2.94, with a year-on-year change of 25.26.

What is the Return on Equity (ROE) of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its Return on Equity (ROE) was -89.65, with a year-on-year change of -140.27.

What is the Return on Assets (ROA) of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its Return on Assets (ROA) was -36.58, with a year-on-year change of -48.62.

What is the operating profit of AC Immune SA?

According to AC Immune SA's FY2025 earnings report, its operating profit was -87.04M, with a year-on-year change of -46.54.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.